1. Background {#sec0005}
=============

Human rhinoviruses (HRV) are a frequent cause of upper respiratory tract infections (URTI). However, recently, HRV were found also to be associated with lower respiratory infections (LRTI), such as bronchiolitis [@bib0005], pneumonia, exacerbation of asthma or cystic fibrosis [@bib0010], [@bib0015], chronic obstructive pulmonary disease [@bib0020] and hospitalization [@bib0025].

HRV are non-enveloped positive-sense single strand RNA viruses, with a 7200-base genome, classified into three species within the *Enterovirus* genus of picornaviruses.

By phylogenetic analysis, reference serotypes have been classified in 75 HRV-A and 25 HRV-B genotypes [@bib0030] and a new species HRV-C, with 50 accepted genotypes and 13 provisionally assigned types (pat), was described in 2006 [@bib0035].

All 3 HRV species have a global distribution, being HRV-A and HRV-C the most prevalent; a high number of co-circulating genotypes were reported. It remains controversial whether a particular species is associated with higher severity and worse outcome.

2. Objectives {#sec0010}
=============

To determine the molecular epidemiology of HRV in hospitalized or outpatient children younger than 6 years old with acute respiratory infection (ARI), without comorbidities. To compare demographic, clinical data, outcome and severity among different HRV species.

3. Study design {#sec0015}
===============

3.1. 1-Study population {#sec0020}
-----------------------

A cross-sectional, descriptive study was performed in 620 children with ARI, without comorbidities, during two consecutive years (June 1, 2008--May 31, 2010) in Buenos Aires, Argentina. Children hospitalized at either Centro de Educación Médica e Investigaciones Clínicas (CEMIC) University Hospital or Mater Dei Hospital, or outpatients attending the emergency room at CEMIC Hospital were enrolled.

Inclusion criteria were: (a) children \<6 years old with LRTI and/or URTI, and symptoms onset ≤3 days; (b) informed consent form signed by parents/tutors; (c) a respiratory sample obtained at admission; (d) demographic and clinical data recorded in a specially designed form. For inpatients, the clinical course including length of stay, oxygen therapy, admission at intensive care unit and mechanical ventilation, was also recorded.

The exclusion criteria were children with cardiopathy, chronic pulmonary disease, metabolic and genetic diseases or immunosuppression.

Nasopharyngeal flocked swabs and aspirates obtained from outpatients and inpatients, respectively, were processed for rapid antigen detection by immunofluorescence (IF) for respiratory syncytial virus (RSV), adenovirus (AdV), influenza A and B (FluA, FluB), parainfluenza (PIV) 1--3 (Chemicon/Millipore) and human metapneumovirus (hMPV) (Argene).

3.2. Rhinovirus detection and typing {#sec0025}
------------------------------------

Viral RNA/DNA extraction was manually performed from an aliquot of the original sample stored at −70 °C, using the QIAamp MinElute Virus Spin (Qiagen), according to the manufacturer\'s recommendations.

HRV detection was performed by a real-time RT-PCR targeting 207 nucleotides (nt) of the 5′ non-coding region (5′NCR), using the One step RT-PCR Kit (Qiagen), primers forward (5′-CYA GCC TGC GTG GC-3′) and reverse (5′-GAA ACA CGG ACA CCC AAA GTA-3′), and a Taqman probe (5′-FAM-TCC TCC GGC CCC TGA ATG YGG C-BHQ1-3′) [@bib0040].

For HRV genotyping, an RT-PCR that amplifies 549 nt of the 5′NCR/VP4/VP2 region was performed according to a previously published protocol using primer pair 9565-reverse and 9895-forward [@bib0045]. PCR products were purified by ethanol precipitation and direct-sequenced by an automatic sequencer 3730XL (Macrogen, Korea).

To type HRV positive cases, 45 samples were selected from both, hospitalized and outpatient children, from every month of the studied period. For inpatients, we selected patients based on their length of stay at the hospital (less or more than 3 days). Strains were named BA (for Buenos Aires), followed by an identification number, a status identification (HL3 stands for hospitalized ≤3 days, HM3 for hospitalized \>3 days, and A for outpatients), and the sample collection date (dd-mm-yy).

Sequences corresponding to 420 nt of the VP4/VP2 partial region, were visually inspected and manually edited with BioEdit v7.0.5.3 [@bib0050], and aligned with ClustalW v1.81 [@bib0055] using GenBank reference sequences for all HRV genotypes and human enterovirus (HEV) species as outgroup.

The obtained HRV sequences were submitted to GenBank under the following accession numbers: [KF146656](ccdc:KF146656){#intr0005}--[KF146699](ccdc:KF146699){#intr0010}.

3.3. Phylogenetic analysis {#sec0030}
--------------------------

A maximum likelihood methodology was employed to study the relationship between obtained HRV sequences and reference strains. Phylogenetic trees were obtained by the heuristic search as implemented in PhyML v3.0 program [@bib0060]. The models of nucleotide substitution were selected according to the Akaike Information Criterion implemented in ModelTest 3.07 [@bib0065]. Branch support was assessed by non-parametric bootstrap (1000 pseudoreplicates). Bootstrap values greater than 70% was used to provide significant evidence for phylogenetic grouping. For recombination analysis, the sequence dataset was examined using bootscan algorithm [@bib0070].

3.4. Demographic reconstruction {#sec0035}
-------------------------------

A Bayesian coalescent analysis was carried out to study the relationship between the different HRV-A and C genotypes. Population dynamics and phylogeny were jointly estimated in a Bayesian framework as implemented in BEAST v1.7.1 [@bib0075]. Sampling dates were used to calibrate an uncorrelated log-normal relaxed molecular clock. Population dynamics was modeled by the non-parametric Bayesian skyline plot (BSP) [@bib0080]. Results were summarized into maximum clade credibility (MCC) trees with branches scaled in time, using Tree Annotator v1.7.1.

3.5. Statistical analysis {#sec0040}
-------------------------

Results were given as percentages for discrete variables and as median, first and third quartile for continuous variables. Bi-variate associations between variables were assessed by χ^2^ or Fisher exact test. Continuous variables were compared using Wilcoxon non-parametric test. The odds ratios (OR) with 95% confidence intervals (CI) were calculated. Statistical significance was assumed for *p* values \<0.05. Statistical analysis was performed using STATA 7.0 (Stata Corp.).

4. Results {#sec0045}
==========

A HRV diagnosis was achieved in 252/620 (40.6%) children \<6 years of age with ARI. Specifically, HRV were detected in 202/434 (46.5%) inpatients, and 50/186 (26.9%) outpatients (*p*  \< 0.01).

Viral antigen detection by IF was positive in 277/620 (44.7%) children. RSV was detected in 165 (26.6%), hMPV in 53 (8.5%), followed by FluA (3.4%), PIV (3.2%), AdV (2.4%) and FluB (1.9%). A viral coinfection was observed in 61 (9.8%) patients, being HRV detected in 53 (8.5%) of them. A total of 144 (23.2%) children had a negative viral diagnosis.

HRV were significantly more frequent in hospitalized patients and the presence of HRV as a single agent or in coinfection were identified as a risk factor for hospitalization: OR: 2.23 (95% CI: 1.51--3.30) and OR: 2.47 (95% CI: 1.60--4.00), respectively.

Of 252 HRV positive patients, 123 (48.8%) were \<12 months, while 195 (77.4%) were \<2 years old. Most were males (60.3%) and breastfed (89.7%) ([Table 1](#tbl0005){ref-type="table"} ). Cough was observed in 90.1% and fever in 57.8% of patients, while tachypnea, wheezing and retraction were recorded in 72.2%, 65.1% and 62.3%, respectively. Almost 70% of children had LRTI, being bronchiolitis the most frequent diagnosis.Table 1Demographic and clinical characteristics of 252 children with HRV, and comparison between species A and C.Total HRV (*n* = 252)HRV-A[b](#tblfn0010){ref-type="table-fn"} (*n* = 24)HRV-C[b](#tblfn0010){ref-type="table-fn"} (*n* = 19)*p*[b](#tblfn0010){ref-type="table-fn"}*n*%*n*%*n*%Age, median (p25--p75)[a](#tblfn0005){ref-type="table-fn"}12 (6--22)8 (4--16)12 (3--26)0.658Male sex15260.31770.8947.40.341Hospitalized20280.21666.71052.60.230Demographic characteristics Breastfeeding22689.72187.519100.00.242 Bronchial hyperreactivity12850.81354.21263.20.756 Familiar bronchial hyperreactivity12047.6937.5736.80.999 Atopy4216.7625.0631.60.737 Familiar atopy7630.2729.2526.30.736 Viral exposure13553.6937.51157.90.228 School siblings14657.91562.5842.10.228 Day care11144.0625.0736.80.509 Passive smoking4517.9729.2736.80.521Signs and symptoms Fever14657.91250.0842.10.760 Tachypnea18272.21666.71473.70.743 Cough22790.12395.81789.50.576 Wheezing16465.11770.81263.20.745 Retraction15762.31562.51368.40.755 Apnea83.214.215.30.999 Cyanosis176.7312.500.00.243 Vomiting4718.7625.0315.80.999Clinical diagnosis URTI7730.5833.3736.80.999 LRTI17569.51666.71263.2  Bronchiolitis13854.81458.31157.90.999  Bronchitis52.000.000.0[c](#tblfn0015){ref-type="table-fn"}  Pneumonia3212.728.315.30.999[^1][^2][^3][^4]

Eighty percent of HRV positive patients were hospitalized: 62.9% had a length of stay of ≤3 days, 72.3% required oxygen supplementation and 10.9% were in intensive care unit (ICU) ([Table 2](#tbl0010){ref-type="table"} ). Of 22 patients in ICU, 5 (22.7%) required mechanical ventilation. None of the children died.Table 2Clinical course of hospitalization among 202 children with human rhinoviruses and comparison between species A and C.Total HRV (*n* = 202)HRV-A[\*](#tblfn0020){ref-type="table-fn"} (*n* = 16)HRV-C[\*](#tblfn0020){ref-type="table-fn"} (*n* = 10)*p*[\*](#tblfn0020){ref-type="table-fn"}*n*%*n*%*n*%Length of stay ≤3 days12762.9743.8550.00.688Length of stay \>3 days7537.1956.3550.0Oxygen supplementation14672.31381.3990.00.280Intensive care requirement2210.9318.8220.00.999Mechanical ventilation52.5212.5110.00.999[^5][^6]

Phylogenetic analysis of 45 BA sequences revealed well-supported groups for all HRV species. HRV-A was the most frequent (55%), followed by HRV-C (43%). Only one strain (2%) grouped with species B. One sample initially diagnosed as HRV, was genotyped as HEV-D68. Thus, HRV typing was performed in 44 patients.

A phylogenetic analysis per species was performed and genotypes were assigned according to the clustering of BA strains with reference sequences ([Fig. 1](#fig0005){ref-type="fig"} ). Thirty different genotypes were detected: 14 HRV-A, 1 HRV-B and 15 HRV-C. The seven most frequent genotypes were observed as monophyletic clusters, named A1--A5 and C1--C2, based on the time of detection. Clusters were genotyped as HRV-A78 (A1), HRV-A55 (A3), HRV-A101 (A4), HRV-A49 (A5), HRV-C10 (C1) and HRV-C40 (C2). Cluster A2 could not be genotyped because the pairwise *p*-distance in VP4/VP2 obtained with the closest reference genotype (HRV-A78) was higher than 12.5%. No recombination events were observed in the analyzed fragment.Fig. 1Phylogenetic analysis of Buenos Aires (BA) strains of HRV (![](fx2_lrg.gif)) species A, B and C identified in hospitalized and outpatient children, from June 2008 to May 2010. BA strains are in bold and were named BA followed by an identification number, a status identification (HL3 stands for hospitalized less than 3 days, HM3 hospitalized more than 3 days, and A outpatients), and the sample collection date (dd-mm-yy). Reference sequences of all HRV species and genotypes were downloaded from GenBank. Phylogenetic tree was constructed by maximum likelihood, using the GTR + I + Γ model for HRV-A, TIM2 + I+ Γ model for HRV-B, and TIM1 + I+ Γ model for HRV-C, using HEV-C to root the tree. Branch support was assessed by bootstrap (1000 pseudoreplicates); values higher than 70% are shown. Purple boxes represent HRV-A clusters, blue boxes represent HRV-C clusters. Branch distance is indicated by the scale bars at the bottom of the trees. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Demographic, clinical characteristics and outcome were similar with either HRV-A (*n*  = 24) or HRV-C (*n*  = 19) ([Table 1](#tbl0005){ref-type="table"}). Of 17 outpatients, 47% had HRV-A and 53% had HRV-C. URTI was observed in 47%, bronchiolitis in 29% and wheezing in 24%. Regarding 27 inpatients, 60% had HRV-A, 37% HRV-C and 1 case HRV-B. Of these, 82% had bronchiolitis, 11% pneumonia and 7% URTI. The clinical outcome, including length of stay, oxygen supplementation, intensive care or mechanical ventilation, was similar with either HRV-A or C ([Table 2](#tbl0010){ref-type="table"}).

HRV circulation occurred throughout the whole year in both years (June 2008--May 2010), with peaks at the beginning of autumn and spring. A variable frequency was observed during winter and a low frequency in summer ([Fig. 2](#fig0010){ref-type="fig"} ). HRV-A and C strains were detected throughout the whole year, and the only HRV-B strain was detected in June, 2009. Several HRV genotypes co-circulate: seven monophyletic clusters, including genetically close strains, predominated during certain months, simultaneously with others genotypes that were detected only once.Fig. 2Seasonality and demographic reconstruction of HRV in Buenos Aires City, Argentina, from June 2008 to May 2010. Total rhinoviruses (green), species A (purple), species B (yellow) and species C (blue). The demographic reconstruction of the 7 monophyletic clusters (A1--A5 and C1--C2) corresponding to 7 different genotypes is represented in the temporal scale showing different common ancestors. BA strains were named by an identification number followed by a status identification (HL3 stands for hospitalized less than 3 days, HM3 hospitalized more than 3 days, and A outpatients). Purple boxes represent the time of detection of the five HRV-A clusters, and blue boxes, the two HRV-C clusters. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

The estimated time of the most recent common ancestor (tMRCA) for the 24 BA strains HRV-A was 18.5 years (highest probability density (HPD) 95%: 5--91), and for the 19 strains HRV-C was 84.8 years (HPD 95%: 11.8--703.0). The substitution rate (expressed in nucleotide substitutions/site/year (s/s/year)) for the VP4/VP2 partial region was also estimated, and was similar for both HRV species: 2.3 × 10^−2^ (HPD 95%: 1.4 × 10^−8^--5.3 × 10^−2^) for HRV-A and 1.9 × 10^−2^ (HPD 95%: 1.1 × 10^−5^--5.8 × 10^−2^) for HRV-C. In addition, the BSP analysis showed a constant demographic profile throughout almost 100 years.

Demographic reconstruction of clusters (A1--A5 and C1--C2) obtained in the MCC trees are shown on a time scale, in order to describe the detection time of the BA strains and the association to their corresponding ancestor, each one belonging to a different HRV genotype ([Fig. 2](#fig0010){ref-type="fig"}). From June 2008 to March 2009, all BA clusters detected were HRV-A (A1--A4). In March and June two HRV-C clusters (C1--C2) appeared, while by the end of the study a different HRV-A cluster (A5) was observed.

5. Discussion {#sec0050}
=============

Our two-year study in children \<6 years presenting ARI reveals that HRV were the most frequently detected viruses. Surprisingly, this frequency was significantly higher in inpatients than in outpatients. Remarkably, all studied patients had no underlying disease [@bib0085]. In the literature, HRV frequencies in children with ARI range from 17% to 44%, depending on the age, onset of disease, season and the RT-PCR employed [@bib0090], [@bib0095], [@bib0100]. However, higher frequencies are usually detected (45--58%) when premature infants and children with wheezing or asthma exacerbation are studied [@bib0010], [@bib0105], [@bib0110].

Regarding the rest of the respiratory viruses studied, RSV was the second in frequency, followed by hMPV, and lower frequencies of the rest. Frequencies for each virus were different in both populations studied: RSV and hMPV were most frequent in hospitalized patients, while FluB and PIV were most frequent in outpatients, as previously described in our hospital [@bib0085]. Although coinfection was observed in a low number of cases, HRV was the most frequently detected. Nosocomial acquisition of these viruses was ruled out since respiratory samples were collected at admission.

The highest frequency of HRV was observed in patients with LRTI, being bronchiolitis the main diagnosis. Surprisingly, 80% of HRV positive children were hospitalized due to their ARI. Furthermore, 11% of patients had very severe ARI as they required ICU or mechanical ventilation. In our study, HRV was identified as a risk factor for ARI which required hospitalization. Case--control studies will be necessary to confirm this finding.

The phylogenetic analysis of BA strains, showed the presence of all HRV species in Buenos Aires: HRV-A and C were more prevalent, while HRV-B was infrequent. These results are consistent with data from the Northern hemisphere, where HRV-A and C are more frequent, and species B is observed in less than 20% of cases [@bib0110], [@bib0115]. To date, few data are available on the detection and molecular epidemiology of HRV in Argentina. Only two recent studies carried out in Latin America reported that HRV frequency ranges from 16% to 34%, and described the 3 HRV species in circulation, with HRV-A and C being the most frequent [@bib0120], [@bib0125].

Regarding seasonality, HRV were detected throughout the 2 years, with peaks in the fall and spring. Species A and C were detected during all the study period, while the single HRV-B was observed in winter. This pattern was similar to that reported in temperate countries [@bib0005], [@bib0130].

A significant genetic diversity of HRV was observed during two consecutive years, evidenced by the high number of genotypes detected and their rapid turnover. Of 30 different genotypes, 7 were detected as monophyletic clusters that circulated on consecutive months. The seasonality pattern of these clusters shows that a frequent HRV genotype may be replaced by a different one. Furthermore, these monophyletic clusters circulated simultaneously with other HRV genotypes detected only once. This observation is consistent with reports describing the simultaneous circulation of a high number of genotypes [@bib0135], [@bib0140].

Interestingly, one HRV-A cluster could neither be genotyped as a known genotype nor as a new recombinant. The pairwise *p*-distance in VP4/VP2 of those strains obtained with the closest reference genotype was higher than 12.5%. According to the proposals for HRV classification, this finding suggests the presence of an undescribed genotype [@bib0035], [@bib0135]. Further studies sequencing the VP1 region are currently ongoing, to determine whether these strains corresponds to a new genotype. One of the sequenced samples was genotyped as HEV-68, usually associated with respiratory diseases [@bib0145].

The demographic reconstruction of BA strains showed that the effective population size remained constant for the last one hundred years for HRV-A and for HRV-C. The tMRCA for HRV-A and C was younger, and the estimated mean rates of evolutionary change for both HRV species were higher (10^−2^  s/s/year), than previously reported (10^−4^  s/s/year) [@bib0150]. Therefore, the estimated mean rates do not represent the mutation rate of each species, but could represent the turnover rate of HRV genotypes. Further studies including more strains from wider periods of time will be necessary to better determine these observations.

Whether one HRV species could be more severe than others has been a matter of discussion. Some authors suggest that HRV-A and B are associated with higher severity [@bib0145], [@bib0155]; others propose that HRV-C cause more severe ARI [@bib0005], [@bib0160], [@bib0165]; there are reports that showed species A and C associated with more severe respiratory illness than HRV-B [@bib0170], while others found no association between severity and HRV species [@bib0025], [@bib0095], [@bib0175], [@bib0180]. Our data showed that all 3 HRV species were detected in severe cases and no differences between HRV-A and HRV-C were observed in the clinical characteristics and outcome.

Our study has some limitations. First, the scarce budget allowed us to genotype only selected and representative HRV strains. Second, the diagnostic procedure used for HRV (real-time RT-PCR) differs from that used for the other respiratory viruses studied (IF). Therefore, due to the lower sensitivity of IF, especially for certain viruses such as AdV or PIV, the frequency of these viruses may be underestimated. Finally, some respiratory viruses such as human coronavirus, bocavirus or PIV-4 were not studied. Therefore, some of the respiratory infections did not get a viral diagnosis.

In summary, this study highlights the clinical impact of HRV in children presenting ARI without comorbidities, as a frequent cause of severe LRTI associated with hospitalization. In Buenos Aires, Argentina, all HRV species were detected, a high number of HRV genotypes co-circulated throughout the whole year, a constant population size and high turnover rate of genotypes was herein estimated. These findings describe the molecular epidemiology of HRV and will help to implement strategies of prevention of HRV infections that will contribute to a better patient\'s management.
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[^1]: HRV: human rhinovirus.

[^2]: Age, median and percentiles 25 and 75 (p25--p75) are given in months.

[^3]: Comparison according to HRV-A or HRV-C detection. Wilcoxon test was used for median comparison. Fisher test was used for all the other demographic and clinical characteristics. Statistical significance was assumed for *p* ≤ 0.05.

[^4]: This value could not be calculated.

[^5]: HRV: human rhinovirus.

[^6]: Fisher test was used for the comparison between children with HRV-A and those with HRV-C. Statistical significance was assumed for *p* ≤ 0.05.
